WHO ICTRP trial
A multi-center, Randomized, Double-blind, Parallel Phase III Clinical Trial to…
KCT0003475 · Clinical Research Information Service (CRIS) · Not Recruiting
Key facts
| Trial ID | KCT0003475 |
|---|---|
| Public title | A multi-center, Randomized, Double-blind, Parallel Phase III Clinical Trial to Evaluate the efficacy and safety of Triple combination therapy of Amlodipine/Valsartan/Rosuvastatin in Paients with Dyslipidemia and Hypertension |
| Scientific title | A multi-center, Randomized, Double-blind, Parallel Phase III Clinical Trial to Evaluate the efficacy and safety of Triple combination therapy of Amlodipine/Valsartan/Rosuvastatin in Paients with Dyslipidemia and Hypertension |
| Primary sponsor | Kyung Dong Pharmaceutical |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Not Recruiting |
| Study type | Interventional Study |
| Phase | Phase3 |
| Countries | Korea, Republic of |
| Conditions | Diseases of the circulatory system |
| Interventions | Drug : 1.Test group : Amlodipine/Valsartan 10/160mg, Rosuvatatin 20mg, Valsartan 160mg(Placebo) ? One 8-week oral administration once a day(Visit your institution every 4 weeks) 2.Reference group1 : Amlodipine/Valsartan 10/160mg… |
| Registration date | Feb 8, 2019 |
| Target size | 174 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: